Aerosol Delivery Devices Market Growth, Demand and Challenges of the Key Industry Players 2028

1
Global Aerosol Delivery Devices Market Research
and Forecast Report 2023-2028




Author Elena Anderson Marketing Manager IMARC
Group
2022 IMARC All Rights Reserved
Copyright IMARC Service Pvt Ltd. All Rights
Reserved
2
About IMARC Group
Report Description
International Market Analysis Research and
Consulting Group is a leading adviser on
management strategy and market research
worldwide. We partner with clients in all regions
and industry verticals to identify their
highest-value opportunities, address their most
critical challenges, and transform their
businesses. IMARCs information products include
major market, scientific, economic and
technological developments for business leaders
in pharmaceutical, industrial, and high
technology organizations. Market forecasts and
industry analysis for biotechnology, advanced
materials, chemicals, food and beverage, travel
and tourism, nanotechnology and novel processing
methods are at the top of the companys
expertise. IMARCs tailored approach combines
unfathomable insight into the dynamics of
companies and markets with close cooperation at
all levels of the client organization. This
ensures that our clients achieve unmatchable
competitive advantage, build more proficient
organizations, and secure lasting results.
3
Report Description and Highlights
Report Description
Global Aerosol Delivery Devices Market Research
Report 2023-2028 According to the latest report
by IMARC Group, titled "Aerosol Delivery Devices
Market Global Industry Trends, Share, Size,
Growth, Opportunity and Forecast
2023-2028," the global aerosol delivery devices
market size reached US 44.4 Billion in 2022.
Aerosol delivery devices refer to an advanced
method of drug administration wherein a drug is
directly delivered to the lungs for a systemic
effect. Some commonly used aerosol delivery
devices include pressurized metered-dose
inhalers, nebulizers, and valved holder chambers.
They are generally used as rescue therapy or
permanent treatment for various respiratory
disorders, such as asthma, obstructive lung
diseases, cystic fibrosis (CF), pulmonary
arterial hypertension, and infectious pulmonary.
They are also utilized in treating
non-respiratory conditions, including diabetes,
analgesia, thyroid disorders, and genetic
diseases. They aid in lowering the dosage
requirements, minimizing systemic adverse
effects, and improving the ability of patients to
self-administer medications. As a result, aerosol
delivery devices find extensive applications in
drug delivery and treatment of various medical
conditions. Request for a PDF sample of this
report https//www.imarcgroup.com/aerosol-deliver
y-devices-market/requestsample

4
Report Description and Highlights
Report Description
Global Aerosol Delivery Devices Market
Trends The rising incidences of chronic
respiratory diseases due to surging air pollution
levels, allergens, occupational risks, and
unhealthy habits like smoking represent the
primary factor driving the market growth.
Moreover, the sudden coronavirus disease
(COVID-19) outbreak that causes acute respiratory
infections among patients is another major
growth-inducing factor. In addition, there has
been widespread adoption of aerosol delivery
devices in treating obstructive airway diseases
at home and in healthcare settings. Along with
this, the expanding geriatric population that is
more susceptible to developing critical health
conditions has augmented the product demand.
Besides this, the increasing preferences for
personalized drug therapy coupled with the advent
of novel macromolecular medications have
propelled market growth. Furthermore, the
leading manufacturers are introducing innovative
product variants that assist in treating chronic
inflammation and infection in the lungs and
improve airway clearance in patients with CF. In
line with this, the development of convenient,
economical, and portable inhalation devices has
accelerated product adoption rates. Apart from
this, the rising usage of e-commerce channels for
purchasing medical supplies and the availability
of mini ultrasonic nebulizers and inhalers that
have automatic memory and are easy to use while
traveling are providing a positive thrust to the
market growth.

5
Report Description and Highlights
Report Description
Looking forward, IMARC Group expects the market
to reach US 63.3 Billion by 2028, exhibiting at
a CAGR of 5.4 during 2023-2028. View Report
TOC, Figures and Tables https//www.imarcgroup.co
m/aerosol-delivery-devices-market

6
Report Description and Highlights
Report Description

• Key Market Segmentation
• The research report includes the following
  segments
• Breakup by Product
• Dry Powder Inhalers
• Single Dose Inhalers
• Multi Dose Inhalers
• Metered Dose Inhalers
• Conventional Pressurized Inhalers
• Soft Mist Inhalers
• Nebulizers
• Jet Nebulizers
• Ultrasonic Wave Nebulizers
• Vibrating Mesh Nebulizers
•  
• Breakup by Application
• Asthma
• Chronic Obstructive Pulmonary Disease (COPD)
• Cystic Fibrosis

7
Report Description and Highlights
Report Description

• Non-Respiratory Diseases
• Diabetes
• Analgesia
• Parkinsons Disease
•  
• Breakup by Distribution Channel
• Retail Pharmacies
• Hospital Pharmacies
• Online Stores
• Breakup by Region
• North America
• Asia Pacific
• Europe
• Latin America
• Middle East and Africa

8
Report Description and Highlights
Report Description

•  
• Competitive Landscape with Key Players
• 3M Company
• Aerogen
• GlaxoSmithKline plc
• Johnson Johnson
• Koninklijke Philips N.V
• Merck Co. Inc
• Metall Zug AG
• Recipharm AB (publ)
• Teva Pharmaceutical Industries Ltd
• Vectura Group plc
•  

9
Key Questions Answered in the Report
Report Description

• What was the size of the global aerosol delivery
  devices market in 2022?
• What is the expected growth rate of the global
  aerosol delivery devices market during 2023-2028?
• What are the key factors driving the global
  aerosol delivery devices market?
• What has been the impact of COVID-19 on the
  global aerosol delivery devices market?
• What is the breakup of the global aerosol
  delivery devices market based on the product?
• What is the breakup of the global aerosol
  delivery devices market based on the distribution
  channel?
• What are the key regions in the global aerosol
  delivery devices market?
• Who are the key players/companies in the global
  aerosol delivery devices market?
•  

10
Table of Contents
Report Description
1    Preface2    Scope and Methodology    2.1
   Objectives of the Study    2.2  
 Stakeholders    2.3    Data Sources       
2.3.1    Primary Sources        2.3.2  
 Secondary Sources    2.4    Market Estimation 
      2.4.1    Bottom-Up Approach        2.4.2  
 Top-Down Approach    2.5    Forecasting
Methodology3    Executive Summary4  
 Introduction    4.1    Overview    4.2    Key
Industry Trends5    Global Aerosol Delivery
Devices Market    5.1    Market Overview    5.2
   Market Performance    5.3    Impact of
COVID-19    5.4    Market Forecast

11
Table of Contents
Report Description
6    Market Breakup by Product    6.1    Dry
Powder Inhalers        6.1.1 Market Trends     
  6.1.2 Key Segments 6.1.2.1 Single
Dose Inhalers 6.1.2.2 Multi Dose
Inhalers    6.2    Metered Dose Inhalers       
6.2.1 Market Trends        6.2.2 Key Segments
6.2.2.1 Conventional Pressurized
Inhalers 6.2.2.2 Soft Mist Inhalers
6.2.3 Market Forecast     6.3  
Nebulizers        6.3.1 Market Trends       
6.3.2 Key Segments  6.3.2.1 Jet
Nebulizers 6.3.2.2 Ultrasonic Wave
Nebulizers         Click here to visit the
complete table of content with list of figures
and tables https//www.imarcgroup.com/aerosol-del
ivery-devices-market/toc

12
Partial List of Clients
We are the trusted business partners to the
world's leading corporates, governments, and
institutions
A partial List of our Clients
13
Partial List of Clients
We are the trusted business partners to the
world's leading corporates, governments, and
institutions
A partial List of our Clients
14
Report Description and Highlights
Report Description

2022 IMARC All Rights Reserved This
Publication and all its contents unless
otherwise mentioned are copyrighted in the name
of International Market Analysis Research and
Consulting (IMARC). No part of this publication
may be reproduced, repackaged, redistributed or
resold in whole or in any part. The publication
may also not be used in any form or by and means
graphic electronic or mechanical, including
photocopying, recording, taping or by information
storage or retrieval, or by any other form,
without the express consent of International
Market Analysis Research and Consulting
(IMARC). Disclaimer All contents and data of
this publication, including forecasts, data
analysis and opinion have been based on
information and sources believed to be accurate
and reliable at the time of publishing.
International Market Analysis Research and
Consulting makes no representation of warranty of
any kind as to the accuracy or completeness of
any Information provided. IMARC accepts no
liability whatsoever for any loss or damage
resulting from opinion, errors or inaccuracies if
any found this publication. IMARC, IMARC Group
and Global Therapy Insight Series are registered
trademarks of International Market Analysis
Research and Consulting. All other trademarks
used in this publication are registered
trademarks of their respective companies.
15

Contact Us